# Amyloidosis Typing Using Mass Spectrometry-based Proteomics: a New Accurate Tool for Difficult Typing

> **NCT03984721** · NA · COMPLETED · sponsor: **University Hospital, Toulouse** · enrollment: 27 (actual)

## Conditions studied

- Amyloidosis

## Interventions

- **DIAGNOSTIC_TEST:** Amyloidosis typing using mass spectrometry-based proteomics

## Key facts

- **NCT ID:** NCT03984721
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-25
- **Primary completion:** 2021-09-08
- **Final completion:** 2021-09-08
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2023-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03984721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03984721, "Amyloidosis Typing Using Mass Spectrometry-based Proteomics: a New Accurate Tool for Difficult Typing". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT03984721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*